Part of the in-depth and practical Pattern Recognition series, Practical Pulmonary Pathology, 4th Edition, helps you arrive at an accurate diagnosis by using a pattern-based approach. Leading diagnosticians in pulmonary pathology offer practical assistance in identifying all major neoplastic and non-neoplastic diseases of the lungs, guiding you from a pathological pattern through the appropriate work-up, around the pitfalls, and to the best diagnosis. More than 1,000 high-quality illustrations capture key morphologic patterns for a full range of common and rare conditions and assist in the interpretation of complex diagnostic puzzles. A unique “visual index at the beginning of the book directs you to the exact chapter and specific page you need for in-depth diagnostic guidance.
Helps you quickly recognize the vast variety of appearances of the lung that result from infections, tumors, and tumor-like lesions, both malignant and benign.
Discusses advances in molecular diagnostic testing, its capabilities and its limitations, including targeted/personalized medicine.
Incorporates clinicopathologic background and relevant data from ancillary techniques (immunohistochemistry, cytogenetics, and molecular genetics), giving you the tools you need to master the latest breakthroughs in diagnostic technology.
Covers the latest TNM staging and WHO classification systems, as well as new diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities.
Color-codes patterns to specific entities, and summarizes key points in tables, charts, and graphs so you can quickly and easily find what you are looking for.
Shares the knowledge and expertise of new co-editor, Dr. Maxwell L. Smith.
1. Introduction - p. 432 2. Pulmonary allograft rejection - p. 433 3. Chronic lung allograft dysfunction - p. 443 4. Infection - p. 445 5. Posttransplantation lymphoproliferative disorders - p. 453 6. Transplantation procedure-related complications - p. 456 7. Recurrence of the primary disease - p. 457 8. Aspiration - p. 458 9. Donor-related pathology - p. 459 10. References - p. 464 11. 14. Neuroendocrine neoplasms of the lung - p. 464 12. Introduction and general considerations - p. 465 13. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia - p. 466 14. Carcinoid tumor - p. 468 15. Atypical carcinoid - p. 473 16. Large cell neuroendocrine carcinoma - p. 476 17. Small cell carcinoma - p. 481 18. Primitive neuroectodermal tumor - p. 486 19. Other rare neuroendocrine tumors - p. 487 20. References - p. 496 21. 15. Sarcomas and sarcomatoid neoplasms of the lungs and pleural surfaces - p. 496 22. Introduction - p. 496 23. General concepts - p. 497 24. Pleomorphic spindle cell neoplasms - p. 498 25. Monomorphic spindle cell neoplasms - p. 514 26. Epithelioid and rhabdoid malignancies - p. 530 27. Small round cell sarcomas - p. 536 28. References - p. 558 29. 16. Hematolymphoid disorders - p. 558 30. Special studies - p. 559 31. Reactive lymphoid proliferations - p. 564 32. Neoplastic and malignant lymphoid proliferations - p. 573 33. Myeloid proliferations - p. 598 34. References - p. 604 35. 17. Non-neuroendocrine carcinomas (excluding sarcomatoid carcinoma) and salivary gland-type tumors of the lung - p. 604 36. 18. Metastatic tumors in the lung: A practical approach to diagnosis - p. 632 37. Pathophysiologic methods of malignant spread - p. 632 38. Pleural metastases - p. 635 39. Endobronchial metastases - p. 638 40. Modalities for the diagnosis of pleuropulmonary metastases - p. 640 41. Practical approach to differential diagnosis - p. 640 42. References - p. 672 43. 19. Pseudoneoplastic lesions of the lungs and pleural surfaces - p. 672 44. 20. Benign and borderline tumors of the lungs and pleura - p. 694 45. Benign pleuropulmonary neoplasms - p. 694 46. Benign tumors that are principally tracheal and endobronchial - p. 695 47. Benign lesions affecting either the airways or the lung parenchyma - p. 708 48. Benign tumors of the pleura - p. 720 49. Biologically borderline tumors of the lung and pleura - p. 723 50. Other lesions - p. 744 51. References - p. 754 52. 21. Malignant and borderline mesothelial tumors of the pleura - p. 754 53. Mesothelioma - p. 754 54. Etiologic considerations in pleural mesothelioma - p. 757 55. Molecular genetics of mesothelioma - p. 758 56. Gross features of pleural mesothelioma - p. 759 57. Histopathologic features of pleural mesothelioma - p. 760 58. Cytopathologic features of pleural mesothelioma - p. 768 59. Histochemical features of pleural mesothelioma - p. 770 60. Electron microscopic features of pleural mesothelioma - p. 770 61. Immunohistochemical findings in pleural mesothelioma - p. 771 62. Differential diagnosis of benign versus malignant mesothelial proliferations - p. 779 63. Differential diagnosis of epithelioid pleural mesothelioma - p. 780 64. Benign and borderline (low-grade malignant) mesothelial tumors - p. 782 65. Staging and grading of malignant mesothelioma - p. 785 66. References - p. 792 67. Appendix: Miscellaneous distinctive histopathologic findings - p. 793 68. Index - p. 811
Part of the in-depth and practical Pattern Recognition series, Practical Pulmonary Pathology, 4th Edition, helps you arrive at an accurate diagnosis by using a pattern-based approach. Leading diagnosticians in pulmonary pathology offer practical assistance in identifying all major neoplastic and non-neoplastic diseases of the lungs, guiding you from a pathological pattern through the appropriate work-up, around the pitfalls, and to the best diagnosis. More than 1,000 high-quality illustrations capture key morphologic patterns for a full range of common and rare conditions and assist in the interpretation of complex diagnostic puzzles. A unique “visual index at the beginning of the book directs you to the exact chapter and specific page you need for in-depth diagnostic guidance.
Helps you quickly recognize the vast variety of appearances of the lung that result from infections, tumors, and tumor-like lesions, both malignant and benign.
Discusses advances in molecular diagnostic testing, its capabilities and its limitations, including targeted/personalized medicine.
Incorporates clinicopathologic background and relevant data from ancillary techniques (immunohistochemistry, cytogenetics, and molecular genetics), giving you the tools you need to master the latest breakthroughs in diagnostic technology.
Covers the latest TNM staging and WHO classification systems, as well as new diagnostic biomarkers and their utility in differential diagnosis, newly described variants, and new histologic entities.
Color-codes patterns to specific entities, and summarizes key points in tables, charts, and graphs so you can quickly and easily find what you are looking for.
Shares the knowledge and expertise of new co-editor, Dr. Maxwell L. Smith.
1. Introduction - p. 432 2. Pulmonary allograft rejection - p. 433 3. Chronic lung allograft dysfunction - p. 443 4. Infection - p. 445 5. Posttransplantation lymphoproliferative disorders - p. 453 6. Transplantation procedure-related complications - p. 456 7. Recurrence of the primary disease - p. 457 8. Aspiration - p. 458 9. Donor-related pathology - p. 459 10. References - p. 464 11. 14. Neuroendocrine neoplasms of the lung - p. 464 12. Introduction and general considerations - p. 465 13. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia - p. 466 14. Carcinoid tumor - p. 468 15. Atypical carcinoid - p. 473 16. Large cell neuroendocrine carcinoma - p. 476 17. Small cell carcinoma - p. 481 18. Primitive neuroectodermal tumor - p. 486 19. Other rare neuroendocrine tumors - p. 487 20. References - p. 496 21. 15. Sarcomas and sarcomatoid neoplasms of the lungs and pleural surfaces - p. 496 22. Introduction - p. 496 23. General concepts - p. 497 24. Pleomorphic spindle cell neoplasms - p. 498 25. Monomorphic spindle cell neoplasms - p. 514 26. Epithelioid and rhabdoid malignancies - p. 530 27. Small round cell sarcomas - p. 536 28. References - p. 558 29. 16. Hematolymphoid disorders - p. 558 30. Special studies - p. 559 31. Reactive lymphoid proliferations - p. 564 32. Neoplastic and malignant lymphoid proliferations - p. 573 33. Myeloid proliferations - p. 598 34. References - p. 604 35. 17. Non-neuroendocrine carcinomas (excluding sarcomatoid carcinoma) and salivary gland-type tumors of the lung - p. 604 36. 18. Metastatic tumors in the lung: A practical approach to diagnosis - p. 632 37. Pathophysiologic methods of malignant spread - p. 632 38. Pleural metastases - p. 635 39. Endobronchial metastases - p. 638 40. Modalities for the diagnosis of pleuropulmonary metastases - p. 640 41. Practical approach to differential diagnosis - p. 640 42. References - p. 672 43. 19. Pseudoneoplastic lesions of the lungs and pleural surfaces - p. 672 44. 20. Benign and borderline tumors of the lungs and pleura - p. 694 45. Benign pleuropulmonary neoplasms - p. 694 46. Benign tumors that are principally tracheal and endobronchial - p. 695 47. Benign lesions affecting either the airways or the lung parenchyma - p. 708 48. Benign tumors of the pleura - p. 720 49. Biologically borderline tumors of the lung and pleura - p. 723 50. Other lesions - p. 744 51. References - p. 754 52. 21. Malignant and borderline mesothelial tumors of the pleura - p. 754 53. Mesothelioma - p. 754 54. Etiologic considerations in pleural mesothelioma - p. 757 55. Molecular genetics of mesothelioma - p. 758 56. Gross features of pleural mesothelioma - p. 759 57. Histopathologic features of pleural mesothelioma - p. 760 58. Cytopathologic features of pleural mesothelioma - p. 768 59. Histochemical features of pleural mesothelioma - p. 770 60. Electron microscopic features of pleural mesothelioma - p. 770 61. Immunohistochemical findings in pleural mesothelioma - p. 771 62. Differential diagnosis of benign versus malignant mesothelial proliferations - p. 779 63. Differential diagnosis of epithelioid pleural mesothelioma - p. 780 64. Benign and borderline (low-grade malignant) mesothelial tumors - p. 782 65. Staging and grading of malignant mesothelioma - p. 785 66. References - p. 792 67. Appendix: Miscellaneous distinctive histopathologic findings - p. 793 68. Index - p. 811
